Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.

Abstract:

:Functional gastrointestinal disorders, such as irritable bowel syndrome and functional dyspepsia, are complex conditions with multiple factors contributing to their pathophysiology. As a consequence they are difficult to treat and have posed significant challenges to the pharmaceutical industry when trying to develop new and effective treatments. This review provides an overview of these difficulties and how the industry is reshaping its drug developmental strategies. It describes some of the more significant and encouraging advances that have occurred, and discusses how future research might embrace the opportunities provided by advances in genetic and in particular, epigenetic research.

authors

Sanger GJ,Chang L,Bountra C,Houghton LA

doi

10.1177/1756283X10369922

subject

Has Abstract

pub_date

2010-09-01 00:00:00

pages

291-305

issue

5

eissn

1756-283X

issn

1756-2848

journal_volume

3

pub_type

杂志文章
  • Effectiveness of endoscopic ultrasound-guided drainage for noncapsulated postoperative pancreatic collection.

    abstract:Background:Postoperative pancreatic collection (POPC) is a frequent complication after pancreatectomy. Although percutaneous drainage (PD) has been the treatment of choice for POPC with encapsulation, endoscopic ultrasound-guided transmural drainage (EUS-TD) was recently reported effective for this condition. The main ...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756284819884418

    authors: Tamura T,Kitano M,Kawai M,Tanioka K,Itonaga M,Kawaji Y,Nuta J,Hatamaru K,Yamashita Y,Kitahata Y,Miyazawa M,Hirono S,Okada KI,Yamaue H

    更新日期:2019-10-24 00:00:00

  • Targeting mucosal healing in Crohn's disease: what the clinician needs to know.

    abstract::In recent years, mucosal healing has emerged as a key therapeutic goal in the clinical management of patients with Crohn's disease, as it has been associated with improved long-term clinical outcomes. With the vast improvements in endoscopic imaging techniques and the increase in available treatment options, which rep...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284819856865

    authors: Klenske E,Bojarski C,Waldner M,Rath T,Neurath MF,Atreya R

    更新日期:2019-06-14 00:00:00

  • Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib.

    abstract::Pancreatic neuroendocrine tumors (pNETs) are relatively rare malignancies. With secretory tumors such as insulinomas, vasoactive intestinal peptideomas, and gastrinomas, the hormone produced causes the symptom complex (e.g. hypoglycemia, peptic ulcer disease). With nonsecretory NETs, the clinical condition is determin...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X13493878

    authors: Vinik AI,Raymond E

    更新日期:2013-09-01 00:00:00

  • Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma.

    abstract:Background:In patients with a large, unresectable hepatocellular carcinoma (HCC), the primary recommendation is for transarterial chemoembolization (TACE) but used alone TACE is not typically curative. Combinations of TACE followed in a delayed fashion by single-applicator thermal ablation have also been suboptimal. As...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756284819862966

    authors: Zhang TQ,Huang ZM,Shen JX,Chen GQ,Shen LJ,Ai F,Gu YK,Yao W,Zhang YY,Guo RP,Chen MS,Huang JH

    更新日期:2019-08-21 00:00:00

  • Prophylaxis of hepatitis B infection in solid organ transplant recipients.

    abstract::Rates of transmission of hepatitis B virus (HBV) infection from organ donors with HBV markers to recipients along with reactivation of HBV during immunosuppression following transplantation have fallen significantly with the advent of hepatitis B immune globulin (HBIg) and effective antiviral therapy. Although the ava...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X13487942

    authors: John S,Andersson KL,Kotton CN,Hertl M,Markmann JF,Cosimi AB,Chung RT

    更新日期:2013-07-01 00:00:00

  • Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

    abstract::Several clinical trials and experimental studies strongly suggest a place for Saccharomyces boulardii as a biotherapeutic agent for the prevention and treatment of several gastrointestinal diseases. S. boulardii mediates responses resembling the protective effects of the normal healthy gut flora. The multiple mechanis...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X11428502

    authors: Kelesidis T,Pothoulakis C

    更新日期:2012-03-01 00:00:00

  • The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment.

    abstract::Chronic hepatitis C (CHC) affects over 185 million individuals worldwide, approximately 3% of the world's population. CHC can lead to quality of life impairment, cirrhosis, hepatocellular carcinoma (HCC), liver failure and liver-related death. While CHC has been associated with increases in HCC, liver-related mortalit...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756283X15587481

    authors: Lam BP,Jeffers T,Younoszai Z,Fazel Y,Younossi ZM

    更新日期:2015-09-01 00:00:00

  • Hereditary pancreatitis for the endoscopist.

    abstract::Hereditary pancreatitis shares a majority of clinical and morphologic features with chronic alcoholic pancreatitis, but may present at an earlier age. The term hereditary pancreatitis has primarily been associated with mutations in the serine protease 1 gene (PRSS1) which encodes for cationic trypsinogen. PRSS1 mutati...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X12467565

    authors: Patel MR,Eppolito AL,Willingham FF

    更新日期:2013-03-01 00:00:00

  • Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance.

    abstract:BACKGROUND:Mast cells (MCs) can stimulate angiogenesis, releasing several proangiogenic cytokines stored in their cytoplasm. In particular, MCs can release tryptase, a potent in vivo and in vitro proangiogenic factor via protease-activated receptor-2 (PAR-2) activation and mitogen-activated protein kinase (MAPK) phosph...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X16673981

    authors: Ammendola M,Sacco R,Vescio G,Zuccalà V,Luposella M,Patruno R,Zizzo N,Gadaleta C,Marech I,Ruggieri R,Kocak IF,Ozgurtas T,Gadaleta CD,Sammarco G,Ranieri G

    更新日期:2017-04-01 00:00:00

  • Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer.

    abstract::Malignant tumor cells are equipped with mechanisms that can help them escape the surveillance by host immune system. Immune checkpoint molecules can transduce coinhibitory signals to immunocompetent cells and exert immunosuppressive roles in antitumor immunity. Programmed death-1 (PD-1) and programmed death ligand-1 (...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756283X16658251

    authors: Liu X,Yang Z,Latchoumanin O,Qiao L

    更新日期:2016-11-01 00:00:00

  • Review of the epidemiology and burden of ulcerative colitis in Latin America.

    abstract::The incidence and prevalence of ulcerative colitis (UC) has been reported to be rising in newly industrialised regions, such as Latin America. Here, we review data from published studies reporting demographics and clinical aspects of UC in Latin America to further understand epidemiology and disease burden. The incide...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284820931739

    authors: Kotze PG,Steinwurz F,Francisconi C,Zaltman C,Pinheiro M,Salese L,Ponce de Leon D

    更新日期:2020-07-09 00:00:00

  • Effective treatment of chronic radiation proctitis using radiofrequency ablation.

    abstract::Endoscopic argon plasma coagulation and bipolar electrocautery are currently preferred treatments for chronic radiation proctitis, but ulcerations and strictures frequently occur. Radiofrequency ablation (RFA) has been successful for mucosal ablation in the esophagus. Here we report the efficacy of RFA with the BarRx ...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283x08103341

    authors: Zhou C,Adler DC,Becker L,Chen Y,Tsai TH,Figueiredo M,Schmitt JM,Fujimoto JG,Mashimo H

    更新日期:2009-01-01 00:00:00

  • Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection.

    abstract:Background:Recurrent Clostridium difficile infection (rCDI) is becoming increasingly common. Faecal microbiota transplantation (FMT) is effective for rCDI, but the costs of an FMT and hospital cost savings related to FMT are unknown. The aim of this study was to calculate the cost of an FMT and the total hospital costs...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756284819843002

    authors: Dehlholm-Lambertsen E,Hall BK,Jørgensen SMD,Jørgensen CW,Jensen ME,Larsen S,Jensen JS,Ehlers L,Dahlerup JF,Hvas CL

    更新日期:2019-04-10 00:00:00

  • External validation of two prediction tools for patients at risk for recurrent Clostridioides difficile infection.

    abstract:Background:One in four patients with primary Clostridioides difficile infection (CDI) develops recurrent CDI (rCDI). With every recurrence, the chance of a subsequent CDI episode increases. Early identification of patients at risk for rCDI might help doctors to guide treatment. The aim of this study was to externally v...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756284820977385

    authors: van Rossen TM,van Dijk LJ,Heymans MW,Dekkers OM,Vandenbroucke-Grauls CMJE,van Beurden YH

    更新日期:2021-01-09 00:00:00

  • Incidence of Clostridioides difficile infection in peripartum women: a retrospective cohort study.

    abstract:Background:The incidence of Clostridioides difficile infection (CDI) is increasing in the general population. Data on the epidemiology of CDI in peripartum women - a highly vulnerable patient population - is scarce. The objective of this study was to report the incidence of CDI in peripartum women. Methods:A single-ce...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756284820942621

    authors: Saha S,Pardi R,Theiler RN,Pardi DS,Khanna S

    更新日期:2020-07-27 00:00:00

  • Bilio-pancreatic endoscopy during COVID-19 pandemic.

    abstract::On 31 December 2019, the WHO China Country Office was informed of cases of pneumonia of unknown etiology detected in Wuhan (Hubei Province of China). In January 2020, a new coronavirus named SARS-CoV2 was isolated and, since that time, SARS-CoV2 related disease (COVID-19) rapidly spread all over the world becoming pan...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284820935187

    authors: Bove V,Schepis T,Boškoski I,Landi R,Orlandini B,Pontecorvi V,Familiari P,Tringali A,Perri V,Costamagna G

    更新日期:2020-06-24 00:00:00

  • Decision model analyses of upper endoscopy for gastric cancer screening and preneoplasia surveillance: a systematic review.

    abstract:Aims:Gastric cancer (GC) is the third leading cause of cancer death worldwide, but the burden of disease is not distributed evenly. GC screening routinely occurs in some high-incidence regions/countries and is generally cost-effective, which is attributed largely to the associated GC mortality reduction. In regions of ...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284820941662

    authors: Canakis A,Pani E,Saumoy M,Shah SC

    更新日期:2020-07-16 00:00:00

  • Targeting neutrophil extracellular traps in severe acute pancreatitis treatment.

    abstract::Severe acute pancreatitis (SAP) is a critical abdominal disease associated with high death rates. A systemic inflammatory response promotes disease progression, resulting in multiple organ dysfunction. The functions of neutrophils in the pathology of SAP have been presumed traditionally to be activation of chemokine a...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284820974913

    authors: Hu J,Kang H,Chen H,Yao J,Yi X,Tang W,Wan M

    更新日期:2020-11-24 00:00:00

  • Advances in therapeutic options for portal hypertension.

    abstract::Portal hypertension represents one of the major clinical consequences of chronic liver disease, having a deep impact on patients' prognosis and survival. Its pathophysiology defines a pathological increase in the intrahepatic vascular resistance as the primary factor in its development, being subsequently aggravated b...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284818811294

    authors: Vilaseca M,Guixé-Muntet S,Fernández-Iglesias A,Gracia-Sancho J

    更新日期:2018-11-25 00:00:00

  • Host-targeting therapies for hepatitis C virus infection: current developments and future applications.

    abstract::Chronic hepatitis C virus (HCV) infection is a leading cause of chronic liver diseases and hepatocellular carcinoma (HCC) worldwide. In the past few years, anti-HCV therapies have undergone a revolution with the approval of multiple direct-acting antivirals (DAAs), which enable interferon-free treatments with consider...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284818759483

    authors: Crouchet E,Wrensch F,Schuster C,Zeisel MB,Baumert TF

    更新日期:2018-03-21 00:00:00

  • Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease.

    abstract::Monoclonal antibodies to tumor necrosis factor (TNF) have become a mainstay of the therapeutic armamentarium in inflammatory bowel disease (IBD) over the last 15 years. Although highly effective, primary and secondary nonresponse are common and associated with poor clinical outcomes and significant costs. Multiple cli...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756283X16638833

    authors: Kopylov U,Seidman E

    更新日期:2016-07-01 00:00:00

  • Prolonged efficacy of pembrolizumab in a patient presenting a multi-treated metastatic hepatocholangiocarcinoma.

    abstract:Introduction:Hepatocholangiocarcinoma (HCC-ICC) is a rare tumor presenting the histologic characteristics of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). As there is no consensus on it management, the therapeutic strategy rests on the specific treatments for HCC or ICC. Programmed cell...

    journal_title:Therapeutic advances in gastroenterology

    pub_type:

    doi:10.1177/1756284820935189

    authors: Saint A,Benchetrit M,Novellas S,Ouzan D,Falk AT,Leysalle A,Barriere J

    更新日期:2020-06-20 00:00:00

  • Erratum for PMID 21180585.

    abstract::Erratum to 'Possible interactions between dietary fibres and 5-aminosalicyclic acid' by C Henriksen, S Hansen, I Nordgaard-Lassen, J Rikardt Anderson and P Madsen. Therapeutic Advances in Gastroenterology (2010) 3(1) 5-9 [DOI: 10.1177/ 1756283X09347810][This corrects the article on p. 5 in vol. 3.]. ...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 已发布勘误

    doi:10.1177/1756283X10363751

    authors:

    更新日期:2012-09-01 00:00:00

  • Clostridium difficile infection: management strategies for a difficult disease.

    abstract::Clostridium difficile was first described as a cause of diarrhea in 1978 and in the last three decades has reached an epidemic state with increasing incidence and severity in both healthcare and community settings. There also has been a rise in severe outcomes from C. difficile infection (CDI). There have been tremend...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756283X13508519

    authors: Khanna S,Pardi DS

    更新日期:2014-03-01 00:00:00

  • Combined radiological-endoscopic management of difficult bile duct stones: 18-year single center experience.

    abstract:OBJECTIVES:Clinical evidence regarding radiological-endoscopic management of intrahepatic bile duct stones is currently lacking. Our aim is to report our 18-year experience in combined radiological-endoscopic management of intrahepatic difficult bile duct stones. METHODS:From June 1994 to June 2012, 299 symptomatic pa...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X15587483

    authors: Cannavale A,Bezzi M,Cereatti F,Lucatelli P,Fanello G,Salvatori FM,Fanelli F,Fiocca F,Donatelli G

    更新日期:2015-11-01 00:00:00

  • Sex-based differences in inflammatory bowel diseases: a review.

    abstract::Sex-based differences in inflammatory bowel disease (IBD) pathogenesis, disease course, and response to therapy have been increasingly recognized, however, not fully understood. Experimental and translational models have been leveraged to investigate hypothesized mechanisms for these observed differences, including th...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284820915043

    authors: Rustgi SD,Kayal M,Shah SC

    更新日期:2020-04-28 00:00:00

  • Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.

    abstract::The treatment of hepatocellular carcinoma (HCC) remains a challenge, with 1- and 3-year survival rates of 20% and 5%, respectively, and a median survival of 8 months. However, a better understanding of the pathogenesis of HCC, and advances in targeted molecular therapies provide physicians treating this disease with n...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X09346669

    authors: Olsen SK,Brown RS,Siegel AB

    更新日期:2010-01-01 00:00:00

  • Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies.

    abstract:BACKGROUND:Some chronic hepatitis C virus (HCV), genotype 1 infected patients treated with direct antiviral agents (DAAs) remain viremic at end of treatment (EOT+), yet go on to achieve sustained virological response 12 weeks after completion of therapy (SVR12). The incidence of EOT+/SVR in patients with genotype 1 and...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X16672392

    authors: Malespin M,Benyashvili T,Uprichard SL,Perelson AS,Dahari H,Cotler SJ

    更新日期:2017-01-01 00:00:00

  • Tools for the tract: understanding the functionality of the gastrointestinal tract.

    abstract::The human gastrointestinal tract comprises a series of complex and dynamic organs ranging from the stomach to the distal colon, which harbor immense microbial assemblages that are known to be vital for human health. Until recently, most of the details concerning our gut microbiota remained obscure. Over the past sever...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X09337646

    authors: Kovatcheva-Datchary P,Zoetendal EG,Venema K,de Vos WM,Smidt H

    更新日期:2009-07-01 00:00:00

  • Chinese herbal medicine for functional dyspepsia: systematic review of systematic reviews.

    abstract:Background:Pharmacotherapy, including prokinetics and proton pump inhibitors for functional dyspepsia (FD) have limited effectiveness, and their safety has been recently questioned. Chinese herbal medicine (CHM) could be considered as an alternative. A systematic review (SR) of SRs was performed to evaluate the potenti...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284818785573

    authors: Chu MHK,Wu IXY,Ho RST,Wong CHL,Zhang AL,Zhang Y,Wu JCY,Chung VCH

    更新日期:2018-07-16 00:00:00